Moreover, Nrf2 has been shown to regulate the immune checkpoint molecule PD-L1 in melanoma, and inhibition of both Nrf2 and PD-1 together leads to a synergic inhibition of tumor growth. The gene discussed is NFE2L2; the disease is neoplasm.